北京大学学报(医学版) ›› 2022, Vol. 54 ›› Issue (2): 217-221. doi: 10.19723/j.issn.1671-167X.2022.02.003

• 论著 • 上一篇    下一篇

单中心就诊2~18岁儿童胆固醇水平异常发生率及病因分析

闫辉1,逄璐2,李雪迎3,杨文双2,蒋世菊2,刘平1,闫存玲2,()   

  1. 1.北京大学第一医院 儿科, 北京 100034
    2.北京大学第一医院 检验科, 北京 100034
    3.北京大学第一医院 医学统计室, 北京 100034
  • 收稿日期:2020-09-07 出版日期:2022-04-18 发布日期:2022-04-13
  • 通讯作者: 闫存玲 E-mail:yancunling@163.com

Incidence and cause of abnormal cholesterol in children aged 2-18 years in a single center

YAN Hui1,PANG Lu2,LI Xue-ying3,YANG Wen-shuang2,JIANG Shi-ju2,LIU Ping1,YAN Cun-ling2,()   

  1. 1. Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
    2. Department of Laboratory, Peking University First Hospital, Beijing 100034, China
    3. Department of Statistics, Peking University First Hospital, Beijing 100034, China
  • Received:2020-09-07 Online:2022-04-18 Published:2022-04-13
  • Contact: Cun-ling YAN E-mail:yancunling@163.com

RICH HTML

  

摘要:

目的: 探讨单中心就诊患儿血浆胆固醇水平异常情况及分布规律。方法: 回顾性分析2016年6月至2019年6月在北京大学第一医院有胆固醇检测结果的2~18岁儿童血浆胆固醇水平。总胆固醇(total cholesterol, TC)采用胆固醇氧化酶法,低密度脂蛋白胆固醇(low-density lipoprotein cholesterol, LDL-C)和高密度脂蛋白胆固醇(high-density lipoprotein cholesterol, HDL-C)采用清除法检测,计数资料比较应用卡方检验。结果: 调查有效数据11 829例,其中男性7 087例, 女性4 742例。TC升高儿童1 822例(15.4%), LDL-C升高儿童1 371例(11.6%),HDL-C降低儿童2 798例(23.7%), 胆固醇水平异常儿童总和4 427例(37.4%)。非常见继发性高脂血症病因就诊儿童7 835人,其中TC升高儿童731例(9.3%), LDL-C升高儿童561例(7.2%), HDL-C降低儿童1 886例(24.1%),胆固醇水平异常儿童总和2 576例(32.9%)。不同疾病就诊儿童中,胆固醇异常发生率差异有统计学意义(P<0.05)。TC升高及LDL-C升高发生率的前三位主要就诊原因均分别为“血脂异常”“泌尿系统疾病”“营养性疾病”。除小儿内科外,其他科室送检的1 257例患儿血脂检测样本中,300例存在胆固醇水平异常(23.8%), 其中高胆固醇血症患儿 70例(5.6%), 高低密度脂蛋白血症患儿44例(3.5%), 低高密度脂蛋白血症患儿224例(17.8%)。在非常见继发性高脂血症病因就诊儿童中,因LDL-C≥140 mg/dL (3.6 mmol/L) 需要进一步排除家族性高胆固醇血症的患儿共365例,占该部分患儿的4.6%。结论: 就诊儿童胆固醇异常发生率高,在原发病诊治的同时加强胆固醇管理不仅有助于控制继发性高胆固醇血症,也为及时发现家族性高胆固醇血症提供可能。

关键词: 高胆固醇血症, 血脂异常, 监测, 儿童

Abstract:

Objective: To investigate the abnormality and distribution of plasma cholesterol levels in single-center hospitalized children. Methods: The blood lipid levels of children aged 2-18 years who had blood lipid test results in Peking University First Hospital from June 2016 to June 2019 were etrospectively analyzed. Cholesterol oxidase method was used for total cholesterol, and high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were detected by clearance method. The counting data were compared with chi-square test. Results: The survey had involved 11 829 children (7 087 were boys and 4 742 were girls). 1 822 (15.4%) children were with elevated total cholesterol, 1 371 (11.6%) children with elevated low-density lipoprotein cholesterol, and 2 798 (23.7%) children with high-density lipoprotein cholesterol reduction. The total number of the children with abnormal cholesterol levels was 4 427 (37.4%). Among the 7 835 children who visited hospital due to the disease not commonly inducing dyslipidemia, 731 (9.3%) had elevated TC, 561 (7.2%) had elevated LDL-C, 1 886 (24.1%) had decreased HDL-C, and 2 576 (32.9%) had abnormal cholesterol levels. Among the children with different diseases, the difference in the incidence of abnormal cholesterol was statistically significant. The top three main groups of the children with increased total cholesterol and low-density lipoprotein cholesterol were “dyslipidemia”, “urinary tract disease”, and “nutritional disease”; The top three main groups of the children with reduced high-density lipoprotein cholesterol were “respiratory diseases”, “dyslipidemia”, “hematological diseases and malignant tumors”. Among the 1 257 blood li-pid test results sent by other departments, 300 cases had abnormal cholesterol levels (23.8%). Among them, there were 70 children with hypercholesterolemia (5.6%), 44 children with increased low-density lipoprotein cholesterol (3.5%), and 224 children with reduced high-density lipoprotein cholesterol (17.8%). There were 365 (4.6%) children with low-density lipoprotein cholesterol ≥140 mg/dL (3.6 mmol/L) who needed to further exclude familiar hypercholesterolemia among the children who visited hospitals due to the disease not commonly inducing dyslipidemia. Conclusion: Children in hospitals have a high incidence of cholesterol abnormalities. Doctors need to pay more attention to the cholesterol diagnosis and management regardless of the discipline, which not only helps to control secondary hypercholesterolemia, but also provides the possibility of detecting familial hypercholesterolemia in time.

Key words: Hypercholesterolemia, Dyslipidemia, Screen, Children

中图分类号: 

  • R725.4

表1

不同疾病种类胆固醇水平异常情况"

Disease classification n TC≥5.18 mmol/L,
n (%)
LDL-C≥
3.37 mmol/L, n (%)
HDL-C≤
1.04 mmol/L, n (%)
Cholesterol level
abnormal, n (%)
Cholesterol level
normal, n (%)
Dyslipidemia 25 11 (44.0) 11 (44.0) 11 (44.0) 17 (68.0) 8 (32.0)
Nutritional diseases 107 17 (15.9) 12 (11.2) 33 (30.8) 47 (43.9) 60 (56.1)
Respiratory diseases 395 15 (3.8) 19 (4.8) 194 (49.1) 210 (53.2) 185 (46.8)
Digestive system
diseases
334 24 (7.2) 26 (7.8) 82 (24.6) 106 (31.7) 228 (68.3)
Urinary system
diseases
2 659 954 (35.9) 712 (26.8) 522 (19.6) 1 350 (50.8) 1 309 (49.2)
Nervous system
disease
2 555 272 (10.7) 194 (7.6) 529 (20.7) 781 (30.6) 1 774 (69.4)
Cardiovascular diseases 833 67 (8.0) 48 (5.8) 211 (25.3) 277 (33.3) 556 (66.7)
Definitively diagnosed
metabolic diseases and
mitochondrial diseases
683 63 (9.2) 47 (6.9) 186 (27.2) 239 (35.0) 444 (65.0)
Endocrine disease 190 16 (8.4) 11 (5.8) 56 (29.5) 70 (36.8) 120 (63.2)
Immune system
diseases
138 13 (9.4) 8 (5.8) 42 (30.4) 51 (37.0) 87 (63.0)
Blood system diseases
and malignant tumors
324 45 (13.9) 32 (9.9) 106 (32.7) 141 (43.5) 183 (56.5)
Others 1 470 87 (5.9) 72 (4.9) 302 (20.5) 393 (26.7) 1 077 (73.3)
Unknown diagnosis 716 62 (8.7) 39 (5.4) 159 (22.2) 218 (30.5) 498 (69.6)
Unwritten diagnosis 1 400 176 (12.6) 140 (10.0) 365 (26.1) 527 (37.6) 873 (62.4)
Total 11 829 1 822 (15.40) 1 371 (11.6) 2 798 (23.7) 4 427 (37.4) 7 402 (62.6)
[1] 中华医学会儿科学分会儿童保健学组, 中华医学会儿科学分会心血管学组, 中华医学会心血管病学分会动脉粥样硬化学组, 等. 儿童青少年血脂异常防治专家共识[J]. 中华儿科杂志, 2009, 47(6):426-428.
[2] Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adole-scents: summary report[J]. Pediatrics, 2011, 128(Suppl 5):213-256.
[3] American Academy of Pediatrics. Committee on Nutrition. American Academy of Pediatrics. Committee on Nutrition. Cholesterol in childhood[J]. Pediatrics, 1998, 101(1 Pt 1):141-147.
doi: 10.1542/peds.101.1.141
[4] Okada T, Murata M, Yamauchi K, et al. New criteria of normal serum lipid levels in Japanese children: the nationwide study[J]. Pediatr Int, 2002, 44(6):596-601.
doi: 10.1046/j.1442-200X.2002.01634.x
[5] Harada-Shiba M, Ohta T, Ohtake A, et al. Guidance for pediatric familial hypercholesterolemia 2017[J]. J Atheroscler Thromb, 2018, 25(6):539-553.
doi: 10.5551/jat.CR002 pmid: 29415907
[6] Rallidis L, Naoumova RP, Thompson GR, et al. Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia[J]. Heart, 1998, 80(6):583-590.
pmid: 10065027
[7] Bornaun H, Öner N, Nişli K, et al. Assessment of lipid profile and some risk factors of atherosclerosis in children whose parents had early onset coronary artery disease[J]. Arch Argent Pediatr, 2017, 115(1):50-54.
doi: 10.5546/aap.2017.eng.50 pmid: 28097840
[8] Hingorani AD, Futema M, Humphries S. Child-parent familial hypercholesterolemia screening in primary care[J]. N Engl J Med, 2017, 376(5):499-500.
[9] Filgueiras MS, Vieira SA, Ribeiro AQ, et al. Family history is associated with the presence of pre-school children[J]. Rev Paul Pediatr, 2019, 37(1):41-48.
doi: 10.1590/1984-0462/;2019;37;1;00005
[10] Ahmad ZS, Andersen RL, Andersen LH, et al. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry[J]. J Clin Lipidol, 2016, 10(5):1223-1229.
doi: 10.1016/j.jacl.2016.07.011
[11] Ding W, Cheng H, Yan Y, et al. 10-year trends in serum lipid levels and dyslipidemia among children and adolescents from several schools in Beijing, China[J]. J Epidemiol, 2016, 26(12):637-645.
doi: 10.2188/jea.JE20140252
[12] Kouda K, Iki M, Fujita Y, et al. Trends in serum lipid levels of a 10- and 13-year-old population in Fukuroi City, Japan (2007—2017)[J]. J Epidemiol, 2020, 30(1):24-29.
doi: 10.2188/jea.JE20180164
[13] 王政和, 邹志勇, 阳益德, 等. 2012年中国7省份6~17岁儿童青少年血脂异常流行情况及相关因素分析[J]. 中华预防医学杂志, 2018, 52(8):798-801.
[14] Pratt RE, Kavey RE, Quinzi D. Combined dyslipidemia in obese children: response to a focused lifestyle approach[J]. J Clin Lipidol, 2014, 8(2):181-186.
doi: 10.1016/j.jacl.2014.01.003
[15] Dowla S, Aslibekyan S, Goss A, et al. Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease[J]. J Clin Lipidol, 2018, 12(4):981-987.
doi: 10.1016/j.jacl.2018.03.089
[16] Wiegman A, Gidding SS, Watts GF, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment[J]. Eur Heart J, 2015, 36(36):2425-2437.
doi: 10.1093/eurheartj/ehv157 pmid: 26009596
[17] Robinson JG. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia[J]. J Manag Care Pharm, 2013, 19(2):139-149.
[1] 赵双云, 邹思雨, 李雪莹, 沈丽娟, 周虹. 中文版口腔健康素养量表简版(HeLD-14)在学龄前儿童家长中应用的信度和效度评价[J]. 北京大学学报(医学版), 2024, 56(5): 828-832.
[2] 陈心心, 唐哲, 乔艳春, 荣文笙. 北京市密云区4岁儿童患龋状况及其与龋活跃性检测的相关性[J]. 北京大学学报(医学版), 2024, 56(5): 833-838.
[3] 岳芷涵,韩娜,鲍筝,吕瑾莨,周天一,计岳龙,王辉,刘珏,王海俊. 儿童早期体重指数轨迹与超重风险关联的前瞻性队列研究[J]. 北京大学学报(医学版), 2024, 56(3): 390-396.
[4] 费秀文,刘斯,汪波,董爱梅. 成人及儿童组织坏死性淋巴结炎临床特征及治疗[J]. 北京大学学报(医学版), 2024, 56(3): 533-540.
[5] 俞光岩. 儿童唾液腺疾病[J]. 北京大学学报(医学版), 2024, 56(1): 1-3.
[6] 吴琦,蔡月明,何娟,黄文蒂,王庆文. 血脂异常与类风湿关节炎肺间质病变的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 982-992.
[7] 闫晓晋,刘云飞,马宁,党佳佳,张京舒,钟盼亮,胡佩瑾,宋逸,马军. 《中国儿童发展纲要(2011-2020年)》实施期间中小学生营养不良率变化及其政策效应分析[J]. 北京大学学报(医学版), 2023, 55(4): 593-599.
[8] 弭小艺,侯杉杉,付子苑,周末,李昕璇,孟召学,蒋华芳,周虹. 中文版童年不良经历问卷在学龄前儿童父母中应用的信效度评价[J]. 北京大学学报(医学版), 2023, 55(3): 408-414.
[9] 崔孟杰,马奇,陈曼曼,马涛,王鑫鑫,刘婕妤,张奕,陈力,蒋家诺,袁雯,郭桐君,董彦会,马军,星一. 不同生长模式与7~17岁儿童青少年代谢综合征的关系[J]. 北京大学学报(医学版), 2023, 55(3): 415-420.
[10] 党佳佳,蔡珊,钟盼亮,王雅琪,刘云飞,师嫡,陈子玥,张依航,胡佩瑾,李晶,马军,宋逸. 室外夜间人工光暴露与中国9~18岁儿童青少年超重肥胖的关联[J]. 北京大学学报(医学版), 2023, 55(3): 421-428.
[11] 陈敬,肖伍才,单蕊,宋洁云,刘峥. DRD2基因rs2587552多态性对儿童肥胖干预效果的影响:一项前瞻性、平行对照试验[J]. 北京大学学报(医学版), 2023, 55(3): 436-441.
[12] 李辉,高阳旭,王书磊,姚红新. 恶性肿瘤患儿完全植入式静脉输液港手术并发症[J]. 北京大学学报(医学版), 2022, 54(6): 1167-1171.
[13] 刘京,陆爱东,左英熹,吴珺,黄志卓,贾月萍,丁明明,张乐萍,秦炯. 儿童急性淋巴细胞白血病合并癫痫发作75例临床特征和预后分析[J]. 北京大学学报(医学版), 2022, 54(5): 948-953.
[14] 崔雅茜,杜军保,张清友,廖莹,刘平,王瑜丽,齐建光,闫辉,徐文瑞,刘雪芹,孙燕,孙楚凡,张春雨,陈永红,金红芳. 儿童直立不耐受和坐位不耐受的疾病谱及治疗方式十年回顾[J]. 北京大学学报(医学版), 2022, 54(5): 954-960.
[15] 马涛,李艳辉,陈曼曼,马莹,高迪,陈力,马奇,张奕,刘婕妤,王鑫鑫,董彦会,马军. 青春期启动提前与儿童肥胖类型的关联研究: 基于横断面调查和队列调查[J]. 北京大学学报(医学版), 2022, 54(5): 961-970.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!